
Protego Biopharma
Developer of a small molecule therapeutics platform designed to reprogram protein folding for the treatment of various systemic amyloid diseases and protein misfolding diseases. The company's drug dis...
Valuation
$216.5M
Latest known
Share Price
N/A
Total Raised
$182.1M
Last Round
N/A